Repligen Reports Fourth Quarter and Full Year 2019 Financial Results

Go back to Repligen Reports Fourth Quarter and Full Year 2019 Financial Results

Repligen (RGEN) Tops Q4 EPS by 2c, Revenues Beat; Offers FY20 EPS/Revenue Guidance

February 20, 2020 7:36 AM EST

Repligen (NASDAQ: RGEN) reported Q4 EPS of $0.20, $0.02 better than the analyst estimate of $0.18. Revenue for the quarter came in at $69.5 million versus the consensus estimate of $68.37 million.

Fourth Quarter 2019 Highlights

Revenue increased by 34% year-over-year as reported (35% at constant currency), to $69.5 millionOrganic revenue growth was 21%GAAP fully diluted EPS was $0.07 compared to $0.12 for the fourth quarter of 2018Adjusted (non-GAAP) fully diluted EPS increased to $0.20 compared to $0.19 for the fourth quarter of 2018

Tony J. Hunt, President and Chief Executive Officer said, We are delighted with the way... More